1st Sep 2022 12:27
Ixico PLC - London-based neuroscience data analytics company - Says that trading in the second half of its financial year ending September 30 is "strong" and expects earnings before interest, tax, depreciation, and amortisation to "comfortably" exceed its previous guidance of GBP1.2 million. Does not give numbers for expected Ebitda. It was GBP1.7 million in financial year 2021. Adds that full-year revenue will be in line with market expectations.
Further, guides to GBP7 million in revenue for financial year 2023, adding that GBP5 million has already been contracted. That is lower than financial year 2021 revenue of GBP9.2 million and financial year 2020 revenue of GBP9.5 million.
Cites diversified order book, with its largest client representing under 15% of projected 2023 revenues. Expects order book at over GBP15 million at year end, up from GBP12.6 million at March 31 but down from GBP18.8 million at September 30, 2021.
Current stock price: 39.41 pence, up 11% on Thursday
12-month change: down 47%
By Tom Budszus; [email protected]
Copyright 2022 Alliance News Limited. All Rights Reserved.
Related Shares:
Ixico